Cel Sci (CVM) Prepaid Assets (2010 - 2026)
Cel Sci (CVM) posted Prepaid Assets of $713916.0 for Q1 2026, up 38.63% sequentially from $514974.0 in Q4 2025, and up 242.47% YoY from $208462.0 in Q1 2025.
Cel Sci (CVM) Prepaid Assets (2010 - 2026) Analysis & Trends
Cel Sci has reported Prepaid Assets for 16 years, with the latest figure at $713916.0 in Q1 2026.
- Quarterly Prepaid Assets rose 242.47% year-over-year to $713916.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $713916.0 (up 242.47% YoY) and the FY2025 annual result came in at $332301.0, up 12.99% from the prior year.
- Prepaid Assets climbed to $713916.0 in Q1 2026 per CVM's latest filing, from $514974.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $986872.0 in Q1 2022 and troughed at $208462.0 in Q1 2025.
- A 5-year average of $536247.8 and a median of $538291.0 in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2025 and 2026: Prepaid Assets tumbled 70.08% in 2025, then soared 242.47% in 2026.
- Over 5 years, Prepaid Assets stood at $538291.0 in 2022, then gained by 2.14% to $549835.0 in 2023, then plunged by 32.15% to $373069.0 in 2024, then surged by 38.04% to $514974.0 in 2025, then soared by 38.63% to $713916.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $713916.0, $514974.0, and $332301.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cel Sci | 2.12 Mn | -4.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 713,916.00 |
| Dec 31, 2025 | 514,974.00 |
| Sep 30, 2025 | 332,301.00 |
| Jun 30, 2025 | 304,133.00 |
| Mar 31, 2025 | 208,462.00 |
| Dec 31, 2024 | 373,069.00 |
| Sep 30, 2024 | 294,097.00 |
| Jun 30, 2024 | 551,337.00 |
| Mar 31, 2024 | 696,648.00 |
| Dec 31, 2023 | 549,835.00 |
| Sep 30, 2023 | 520,368.00 |
| Jun 30, 2023 | 462,848.00 |
| Mar 31, 2023 | 598,377.00 |
| Dec 31, 2022 | 538,291.00 |
| Sep 30, 2022 | 762,063.00 |
| Jun 30, 2022 | 708,621.00 |
| Mar 31, 2022 | 986,872.00 |
| Dec 31, 2021 | 723,782.00 |
| Sep 30, 2021 | 998,482.00 |
| Jun 30, 2021 | 978,575.00 |